Status:
COMPLETED
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Hyperbilirubinemia
Eligibility:
All Genders
24-168 years
Phase:
PHASE3
Brief Summary
Objectives: Bilirubin measured by transcutaneous bilirubinometry (TcB) is a reasonably accurate estimate of serum total bilirubin (STB). Observational studies indicate that replacing clinical assessme...
Detailed Description
Introduction/objectives: As the bilirubin concentration in the serum increases, it is deposited in the skin and subcutaneous tissues, producing the physical sign of jaundice.1 There is a well-establis...
Eligibility Criteria
Inclusion
- Neonates born at 35 or more completed weeks of gestation with clinical jaundice and age between 25 to 168 hours
Exclusion
- Neonates with Rh hemolytic disease those requiring NICU admission for more than 24 h having major congenital malformation or having received phototherapy
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
617 Patients enrolled
Trial Details
Trial ID
NCT00653874
Start Date
November 1 2006
End Date
August 1 2007
Last Update
April 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029